Activation-dependent modulation of hyaluronate-receptor expression and of hyaluronate-avidity by human monocytes

Journal of Investigative Dermatology

Volumn 111, Issue 2, 1998, Pages 227-232

  Weiss, Johannes M ^a   Renkl, Andreas C ^a   Ahrens, Thomas ^a   Moll, Jürgen ^b   Mai, Brigitte H ^a   Denfeld, Ralf W ^a   Schöpf, Erwin ^a   Ponta, Helmut ^b   Herrlich, Peter ^b   Simon, Jan C ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

Author keywords

CD44; ICAM 1; Macrophages; RHAMM

Indexed keywords

CD44V ANTIGEN; HERMES ANTIGEN; HYALURONIC ACID; INTERCELLULAR ADHESION MOLECULE 1; RECEPTOR PROTEIN;

ANTIGEN EXPRESSION; ARTICLE; CONTACT DERMATITIS; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; LEUKOCYTE MIGRATION; MONOCYTE; PRIORITY JOURNAL; PROTEIN DOMAIN; RECEPTOR UPREGULATION; SKIN ALLERGY; SKIN INFLAMMATION;

EID: 7344254615     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.1998.00286.x     Document Type: Article

References (51)

1. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B: CD44 is the principal cell surface receptor for hyaluronate. Cell 61:1303-1313, 1990
2. Assmann V, Marshall JF, Fieber C, Hofmann M, Hart IR: The human hyaluronan receptor RHAMM is expressed as an intracellular protein in breast cancer cells. J Cell Sci 111:1685-1694, 1998
3. Becker D, Knop J: Mechanism in allergic contact dermatitis. Exp Dermatol 2:63-69, 1993
4. Bennett KL, Jackson DG, Simon JC, et al. CD44 isoforms containing exon V3 are responsible tor the presentation of heparin-binding growth factor. J Cell Biol 28:687-698, 1995
5. Camp RL, Kraus TA, Pure E: Variations in the cytoskeletal interaction and posttranslational modification of the CD44 homing receptor in macrophages. J Cell Biol 115:1283-1292, 1991
6. Camp RL, Scheynius A, Johansson C, Pure E: CD44 is necessary for optimal contact allergic responses but is not required for normal leukocyte extravasation. J Exp Med 178:497-507, 1993
7. Campbel RD, Love SH, Whiteheart SW, Young B, Myrvik QN: Increased hyaluronic acid is associated with dermal delayed-type hypersensitivity. Inflammation 6:235-244, 1982a
8. Culty M, O'Mara TE, Underhill CB, Yeager H Jr, Swartz RP: Hyaluronan receptor (CD44) expression and function in human peripheral blood monocytes and alveolar macrophages. J Leuk Biol 56:605-611, 1994
9. DeBelder AN, Wik KO: Preparation of fluorescein-labeled hyaluronate. Carboh Res 44:252-257, 1975
10. Galluzzo E, Albi N, Fiorucci S, et al: Involvement of CD44 variant isoforms in hyaluronate adhesion by human activated T cells. Eur J Immunol 25:2932-2939, 1995
11. Hardwick C, Hoare K, Owens R, et al: Molecular cloning of a novel hyaluronate receptor that mediates tumor cell motility [published erratum appears in J Cell Biol 118:753, 1992]. J Cell Biol 117:1343-1350, 1992
12. Herrlich P, Zoller M, Pals ST, Ponta H: CD44splice variants: metastases meet lymphocytes. Immunol Today 14:395-399, 1993
13. Hodge-Dufour J, Noble PW, Horton MR, et al: Induction IL-12 and chemokines by hyaluronan requires adhesion- dependent priming of resident but not elicited macrophages. J Immunol 159:2492-2500, 1997
14. Hofmann M, Rudy W, Zoller M, Tolg C, Ponta H, Herrlich P, Gunther U: CD44splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines. Cancer Res 51:5292-5297, 1991
15. Hofmann M, Fieber C, Assmann V, et al: Identification of IHABP, a 95 kDa intracellular hyaluronate binding protein. J Cell Sci 111:1673-1684, 1998
16. Hudson DL, Sleeman J, Watt FM: CD44 is the major peanut lectin-binding glycoprotein of human epidermal keratinocytes and plays a role in intercellular adhesion. J Cell Sci 108:1959-1970, 1995
17. Jackson DG, Bell JI, Dickinson R, Timans J, Shields J, Whittle N: Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon. J Cell Biol 128:673-685, 1995
18. Jalkanen S, Saari S, Kalimo H, et al: Lymphocyte migration into the skin: the role of lymphocyte homing receptor (CD44) and endothelial cell antigen (HECA-452). J Invest Dermatol 94:786-792, 1990
19. Kaya G, Rodriguez I, Jorcano JI, Vassalli P, Stamenkovic I: Selective suppression of CD44 in keratinocytes of mice bearing an antisense CD44 transgene driven by a tissue-s specific promoter disrupts hyaluronate metabolism in the skin keratinocyte proliferation. Genes Dev 11:996-1007, 1997
20. Lesley J, Hyman R: CD44 can be activated to function as an hyaluronic acid receptor in normal murine T cells. Eur J Immunol 22:2719-2793, 1992
21. Lesley J, Schulte R, Hyman R: Binding of hyaluronic acid to cell lines is inhibited by monoclonal antibodies against Pgp-1. Exp Cell Res 187:224-233, 1990
22. Lesley J, Hyman R, Kincade PW: CD44 and its interaction with extracellular matrix. Adv Immunol 54:271-335, 1993a
23. Lesley J, Kincade PW: Hyman R: Antibody-induced activation of the hyaluronan receptor function of CD44 requires multivalent binding by antibody. Eur J Immunol 23:1902-1909, 1993b
24. Levesque MC, Haynes BE: In vitro culture of human peripheral blood monocytes induces hyaluronan binding and up-regulates monocytes variant CD44 isoform expression. J Immunol 156, 1557-1565, 1996
25. Mackay CR, Terpe HJ, Stauder R, Marston WI, Stark H, Gunthert U: Impression and modulation of CD44 variant isoforms in humans. J Cell Biol 124:71-82, 1994
26. Masellis-Smith A, Belch AR, Mant MJ, Turley EA, Pilarski LM: Hyaluronan-dependent motility of B cells and leukemic plasma cells in blood, but not of bone marrow plasma cells, in multiple myeloma: alternate use of receptor for hyaluronan-mediated motility (RHAMM) and CD44. Blood 87:1891-1899, 1996
27. McCourt PA, Ek B, Forsberg N, Gustafson S: Intercellular adhesion molecule-1 is a cell surface receptor for hyaluronan. J Biol Chem 269:30081-30084, 1994
28. Noble PW, Lake FR, Henson PM, Riches DW: Hyaluronate activation of CD44 induces insulin-like growth factor-1 expression by a tumor necrosis factor-alpha-dependent mechanism in murine macrophages. J Clin Invest 91:2368-2377, 1993
29. Noble PW, McKee CM, Cowman M, Shin HS: Hyaluronan fragments activate an NF-kB/1-kβα autoregulatory loop in murine macrophages. J Exp Med 183:2373-2378, 1996
30. Peach RJ, Hollenbaugh D, Stamenkovic I, Aruffo A: Identification of hyaluronic acid binding sites in the extracellular domain of CD44. J Cell Biol 122:257-264, 1993
31. Perschl A, Lesley J, English N, Trowbridge I, Hyman R: Role of CD44 cytoplasmic domain in hyaluronan binding. Eur J Immunol 25:495-501, 1995
32. Pure E, Camp RL, Peritt D, Panettieri RA Jr, Lazaar AL, Nayak S: Defective phosphorylation and hyaluronate binding of CD44 with point mutations in the cytoplasmic domain. J Exp Med 181:55-62, 1995
33. Samuel SK, Hurta RA, Spearman MA, Wright JA, Turley EA, Greenberg AH: TGF-beta I stimulation of cell locomotion utilizes the hyaluronan receptor RHAMM and hyaluronan. J Cell Biol 123:749-758, 1993
34. Savani RC, Wang C, Yang B, et al: Migration of bovine aortic smooth muscle cells after wounding injury. The role of hyaluronan and RHAMM. J Clin Invest 95:1158-1168, 1995
35. Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth U, Bell JI: Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 89:12160-12164, 1992
36. Sherman L, Sleeman J, Herrlich P, Ponta H: Hyaluronate receptors: key players in growth, differentiation, migration and tumor progression. Can Opin Cell Biol 6:726-733, 1994
37. Simon JC, Dietrich A, Mielke V, et al: Expression of the B7/BB1 activation antigen and its ligand CD28 in I-cell-mediated skin diseases. J Invest Dermatol 103:539-543, 1994
38. Simon JC, Dittmar HC, de Roche R, Wilting J, Christ B, Schöpf E: Rapid purification of human Langerhans cells using paramagnetic microbeads. Exp Dermatol 4:155-161, 1995
39. Simon JC, Heider KH, Dietrich A, et al: Expression of CD44 isoforms in human skin cancer. Eur J Cancer 32A:1394-1400, 1996
40. Sleeman J, Rudy W, Hofmann M, Moll J, Herrlich P, Ponta H: Regulated clustering of variant CD44 proteins increases their hyaluronate binding capacity. J Cell Biol 133:1139-1151, 1996
41. Spring FA, Gardner B, Judson PA, et al (eds): Epitope mapping of CD44 MoAb In: Leucocyte Typing I: White Cell Differentiation Antigens. Oxford University Press, Oxford, 1995, pp. 1738-1740
42. Sy MS, Guo YJ, Stamenkovic I: Distinct effects of two CD44 isoforms on tumor growth in vivo. J Exp Med 174:859-866, 1991
43. Tammi R, Agren UM, Tuhkanen A-L, Tammi M: Hyaluronan Metabolism in Skin. New York, Gustav Fischer Verlag, 1994
44. Thomas I, Byers HR, Vink J, Stamenkovic I: CD44H regulates tumor cell migration on hyaluronate-coated substrate. J Cell Biol 118:971-977, 1992
45. Thomas I, Etoh T, Stamenkovic I, Mihni MC Jr, Byers HR: Migration of human melanoma cells on hyaluronate is related to CD44 expression. J Invest Dermatol 100:115-120, 1993
46. Turley EA, Belch AJ, Poppena S, Pilarski IM: Expression and function of a receptor for hyaluronan-mediated motility on normal and malignant B lymphocytes. Blood 81:446-453, 1993
47. Turley EA, Hossain MZ, Sorokan T, Jordan IM, Nagy JI: Astrocyte and microglial motility in vitro is functionally dependent on the hyaluronan receptor RHAMM. GLIA 12:68-80, 1994
48. Uff CR, Neame SJ, Isake CM: Hyaluronan binding by CD44 is regulated by a phosphorylation-independent mechanism. Eur J Immunol 25:1883-1887, 1995
49. Wang C, Entwistle J, Hou G, Li Q, Turley LA: The characterization of a human RHAMM cDNA, conservation of the hyaluronate-binding domains. Gene 174:299-306, 1996
50. Webb DS, Shimizu Y, Van Seventer GA, Shaw S, Gerard H: LFA-3, CD44, and CD45: physiologic triggers of human monocyte TNF 11-1 release. Science 249:1295-1297, 1990
51. Weiss JM, Renkl AC, Denfield RW, de Roche R, Schöpf E, Simon JC: Low-dose UVB radiation perturbs the functional expression of B7.1 and B7.2 co-stimulatory molecules on human Langerhans cells. Eur J Immunol 25:2858-2862, 1995